Stephen Hunter

Summary

Affiliation: Emory University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue
    Stephen B Hunter
    Department of Pathology and Laboratory Medicine, Emory University Hospital, H 173, 1364 Clifton Rd NE, Atlanta, GA 30322, USA
    J Histochem Cytochem 53:963-9. 2005
  2. ncbi request reprint Expression microarray analysis of brain tumors: what have we learned so far
    Stephen B Hunter
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30087, USA
    Front Biosci 7:c74-82. 2002
  3. ncbi request reprint Apolipoprotein D is down-regulated during malignant transformation of neurofibromas
    Stephen Hunter
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Hum Pathol 36:987-93. 2005
  4. ncbi request reprint Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review)
    Stephen B Hunter
    Department of Pathology and Laboratory Medicine, Emory University Hospital, H 173, NE, Atlanta, GA 30322, USA
    Int J Oncol 23:857-69. 2003
  5. ncbi request reprint Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms
    Stephen Hunter
    Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    J Neuropathol Exp Neurol 61:275-81. 2002
  6. doi request reprint Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics
    Christina L Appin
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Brain Pathol 23:454-61. 2013
  7. pmc Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis
    Ling Qi
    Department of Pathology and Laboratory Medicine, Radiation Oncology, and Neurosurgery, Winship Cancer Institute, Emory University School Medicine, 1365 C Clifton Road, Atlanta, GA 30322, USA
    Apoptosis 16:1150-64. 2011
  8. ncbi request reprint Immunohistochemical demonstration of isocitrate dehydrogenase 1 (IDH1) mutation in a small subset of prostatic carcinomas
    Shakuntala H Mauzo
    Departments of Pathology and Laboratory Medicine Urology Radiation Oncology, Emory University School of Medicine, Atlanta, GA
    Appl Immunohistochem Mol Morphol 22:284-7. 2014
  9. ncbi request reprint Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
    Anita C Bellail
    Laboratory of Molecular Neuro Oncology, Department of Neurosurgery, Hematology Oncology, Winship Cancer Institute and Brain Tumor Program, Emory University, Atlanta, GA 30322, USA
    Int J Biochem Cell Biol 36:1046-69. 2004
  10. ncbi request reprint Genetic markers in glioblastoma: prognostic significance and future therapeutic implications
    Charles Hill
    Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA
    Adv Anat Pathol 10:212-7. 2003

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue
    Stephen B Hunter
    Department of Pathology and Laboratory Medicine, Emory University Hospital, H 173, 1364 Clifton Rd NE, Atlanta, GA 30322, USA
    J Histochem Cytochem 53:963-9. 2005
    ..ApoD expression measured by quantitative RT-PCR may be useful in the differential diagnosis of primary brain tumors, particularly pilocytic astrocytomas and gangliogliomas...
  2. ncbi request reprint Expression microarray analysis of brain tumors: what have we learned so far
    Stephen B Hunter
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30087, USA
    Front Biosci 7:c74-82. 2002
    ..Finally, novel roles for a few genes, including insulin growth factor binding protein 2 and apolipoprotein D, have been revealed for the first time by expression microarrays...
  3. ncbi request reprint Apolipoprotein D is down-regulated during malignant transformation of neurofibromas
    Stephen Hunter
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Hum Pathol 36:987-93. 2005
    ..This expression pattern may serve as a marker for cell cycle inhibition during peripheral nerve tumorigenesis...
  4. ncbi request reprint Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review)
    Stephen B Hunter
    Department of Pathology and Laboratory Medicine, Emory University Hospital, H 173, NE, Atlanta, GA 30322, USA
    Int J Oncol 23:857-69. 2003
    ..Although at the present no molecular system for the classification of brain tumors has been generally accepted, microarray technologies offer the exciting prospect of practical molecular classification in the future...
  5. ncbi request reprint Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms
    Stephen Hunter
    Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    J Neuropathol Exp Neurol 61:275-81. 2002
    ..ApoD might play a role in either decreased proliferation or cyst formation in pilocytic astrocytomas, gangliogliomas, SEGAs, and PXAs...
  6. doi request reprint Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics
    Christina L Appin
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Brain Pathol 23:454-61. 2013
    ..Among patients with GBM-O, younger age at presentation and 1p deletion were most significant in conferring prolonged survival. Thus, GBM-O represents a subset of GBMs with distinctive morphologic, clinical and molecular characteristics...
  7. pmc Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis
    Ling Qi
    Department of Pathology and Laboratory Medicine, Radiation Oncology, and Neurosurgery, Winship Cancer Institute, Emory University School Medicine, 1365 C Clifton Road, Atlanta, GA 30322, USA
    Apoptosis 16:1150-64. 2011
    ..Clinic trials may consider genomic analysis of the cancer tissue to identify the genomic loss of CASP8 and use it as a genomic marker to predict the resistance of glioblastomas to TRAIL apoptosis pathway-targeted therapies...
  8. ncbi request reprint Immunohistochemical demonstration of isocitrate dehydrogenase 1 (IDH1) mutation in a small subset of prostatic carcinomas
    Shakuntala H Mauzo
    Departments of Pathology and Laboratory Medicine Urology Radiation Oncology, Emory University School of Medicine, Atlanta, GA
    Appl Immunohistochem Mol Morphol 22:284-7. 2014
    ..This study indicates that IHC is a reliable method for the pathologic identification of the IDH1 mutation in solid human cancers such as prostate carcinomas. ..
  9. ncbi request reprint Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
    Anita C Bellail
    Laboratory of Molecular Neuro Oncology, Department of Neurosurgery, Hematology Oncology, Winship Cancer Institute and Brain Tumor Program, Emory University, Atlanta, GA 30322, USA
    Int J Biochem Cell Biol 36:1046-69. 2004
    ..This review will focus on the impact of microregional heterogeneity of the ECM on glioma invasion in the normal adult brain and its modifications in tumoral brain...
  10. ncbi request reprint Genetic markers in glioblastoma: prognostic significance and future therapeutic implications
    Charles Hill
    Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA
    Adv Anat Pathol 10:212-7. 2003
    ..It remains to be seen if GBMs with 1p and 19q losses are chemosensitive in the same manner as oligodendrogliomas...